{
    "Trade/Device Name(s)": [
        "VITEK 2 AST-Yeast Fluconazole",
        "VITEK 2 AST-YS Fluconazole"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K213241",
    "Predicate Device Reference 510(k) Number(s)": [
        "K133817"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "September 29, 2021",
    "Summary Letter Received Date": "September 30, 2021",
    "Submission Date": "September 29, 2021",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility System"
    ],
    "Analyte Class(es)": [
        "mycology"
    ],
    "Analyte(s)": [
        "Fluconazole"
    ],
    "Specimen Type(s)": [
        "Yeast isolates",
        "Candida species"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITEK 2 System",
        "VITEK 2 Compact System"
    ],
    "Method(s)/Technology(ies)": [
        "Microdilution minimum inhibitory concentration (MIC)",
        "Automated quantitative antimicrobial susceptibility testing"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing",
        "Doubling dilution technique"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Automated system"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK 2 AST-Yeast Fluconazole assay for antifungal susceptibility testing of Candida species using automated MIC determination.",
    "Indications for Use Summary": "Intended as a laboratory aid for in vitro quantitative susceptibility testing of Candida species to Fluconazole with VITEK 2 Systems to determine antifungal susceptibility.",
    "fda_folder": "Microbiology"
}